Physician and patient survey of allergic rhinitis in France: Perceptions on prevalence, severity of symptoms, care management and specific immunotherapy

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 63, Issue 8, 2008, Pages 1008-1014

  Demoly, P ^a   Didier, A ^b   Mathelier Fusade, P ^c   Drouet, M ^d   David, M ^e   Bonnelye, G ^f   De Blic, J ^g   Klossek, J M ^h  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b SERVICE DE PNEUMOLOGIE   (France)

^c CHU Angers ^*

^d ANGERS UNIVERSITY HOSPITAL   (France)

^e Stallergenes SA   (France)

^f TNS Healthcare   (France)

^g HÔPITAL NECKER ENFANTS MALADES   (France)

^h University of Poitiers   (France)

Author keywords

Allergic rhinitis; Prevalence; Specific immunotherapy; Survey; Symptoms

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID;

ADULT; ALLERGIC RHINITIS; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FRANCE; HEALTH SURVEY; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; STRUCTURED QUESTIONNAIRE; ADOLESCENT; FEMALE; HAY FEVER; HOSPITALIZATION; MALE; METHODOLOGY; MIDDLE AGED; PATIENT SATISFACTION; QUESTIONNAIRE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; FEMALE; FRANCE; HEALTH SURVEYS; HUMANS; IMMUNOTHERAPY; MALE; MIDDLE AGED; PATIENT SATISFACTION; PREVALENCE; QUESTIONNAIRES; RHINITIS, ALLERGIC, SEASONAL; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 56149123212     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2008.01666.x     Document Type: Article

References (24)

1. Neukirch F, Pin I, Knani J, Henry C, Pison C, Liard R et al. Prevalence of asthma and asthma-like symptoms in three French cities. Res Med 1995;89:685-692
2. Asher MI, Montefort S, Bj̈orkste;nB, Lai CK, Strachan DP, Weiland SK et al. ISAAC Phase Three Study Group. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006;368:733-743
3. Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 2004;24:758-764
4. Demoly P, Allaert FA, Lecasble M. PRAGMA. ERASM, a pharmacoepidemiologic survey on management of intermittent allergic rhinitis in every day general medical practice in France. Allergy 2002;57:546-554
5. Bousquet J, Knani J, Dhivert H, Richard A, Chicoye A, Ware JE Jr et al. Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire. Am J Respir Crit Care Med 1994;149:371-375
6. ARIA. Allergic rhinitis and its impact on asthma. ARIA workshop report. J Allergy Clin Immunol 2001; 108(5 Sup-pl.):1-205
7. Calderon M, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 2007;24:CD001936
8. Abramson MJ, Puy RM, Weiner JM. Allergen immunotherapy of asthma. Cochrane Database Syst Rev 2003;4:CD001186
9. Wilson DR, Lima MT, Durham SR.Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005;60:4-12
10. 10.Penagos M, Compalati E, Tarantini F, Baena-Cagnani R, Huerta J, Passalacqua G et al. Efficacy of sublin-gual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol 2006;97:141-148
11. Calamita Z. Review about sublingual immunotherapy in asthma: reply letter.Allergy 2007;62:706-707
12. Deville JC. A theory of quota surveys. Survey Methodol 1991;17:163-181
13. Annesi-Maesano I, Didier A, Klossek JM, Chanal I, Moreau D, Bousquet J. Le Score For Allergic Rhinitis (SFAR): version francaise. Rev Fr Allergol Immunol Clin 2004;44:396-399
14. Nelson HS. Advances in upper airway diseases and allergen immunotherapy. J Allergy Clin Immunol 2007;119:872-880
15. Ross RN. The cost of allergic rhinitis.Am J Man Care 1996;2:285- 290
16. Settipane RA. Complications of allergic rhinitis. Allergy Asthma Proc 1999;20:209-213
17. Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 2001;108(1 Suppl.):S45-S53
18. Blaiss M. Current concepts and therapeutic strategies for allergic rhinitis in school-age children. Clin Ther 2004;26:1876-1889
19. Nassef M, Shapiro G, Casale TB, Respiratory &Allergic Disease Foundation. Identifying and managing rhinitis and its subtypes: allergic and nonallergic components a consensus report and materials from the Respiratory &Allergic Disease Foundation.Curr Med Res Opin 2006;22:2541-2548
20. Linneberg A, Henrik Nielsen N, Frolund L, Madsen F, Dirksen A, Jorgensen T, Copenhagen Allergy Study. The link between allergic rhinitis and allergic asthma: a prospective population-based study. The Copenhagen Allergy Study. Allergy 2002;57:1048-1052
21. Dahl R, Kapp A, Colombo G, De Monchy JG, Rak S, Emminger W et al. Efficacy and safety of sublingual immu-notherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006;118:434-440
22. Didier A, Malling H-J, Worm M, Horak F, Jager S, Montagut A et al. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol 2007;120:1338-1345
23. Passalacqua G, Durham SR, Global Allergy and Asthma European Network. Allergic rhinitis and its impact on asthma update: allergen immuno-therapy. J Allergy Clin Immunol 2007;119:881-891
24. Jacobsen L, Valovirta E. How strong is the evidence that immunotherapy in children prevents the progression of allergy and asthma? Curr Opin Allergy Clin Immunol 2007;7:556-560